RNA Outsourcing Solutions
-
Help Your Program Thrive With inSeption Group
6/13/2024
Experience the difference that dedicated, top-tier professionals can make in achieving excellence and innovative solutions in clinical outsourcing.
-
Toxicology Support: Regulatory Strategy And Submission Support
12/2/2025
Eliminate delays and ensure seamless regulatory alignment with an experienced toxicology services team.
-
RNA Therapies
5/15/2024
One Team, One Roof, One CDMO
Recipharm Advanced Bio's expanded biologics services and technologies encompass the entire RNA development and manufacturing value chain, helping to deliver your innovation to patients seamlessly.
-
DasherGRP mRNA: Optimized Fluorescent Protein
5/6/2026
Fluorescent mRNA reporters enable rapid visual confirmation of delivery and expression in mammalian cells, with bright signal, transient expression, and quantitative readouts.
-
Two Sites, One Standard of Excellence
10/22/2025
Secure your supply chain with a trusted partner in sterile manufacturing. Discover a dual-site strategy that offers crucial redundancy, high regulatory confidence, and a proven approach to efficient tech transfer.
-
Biologics Development
5/15/2024
Recipharm Advanced Bio offers industry-leading biologics development services to support global clients in all clinical phases and global regulatory arenas. Our comprehensive development services include both process and formulation development.
-
mRNA Vaccines And Therapeutics
1/28/2025
With our scale and experience in both chemistry and biologics, Curia is uniquely positioned to provide mRNA drug development solutions.
-
Services For Advancing mRNA-LNPs From Bench To Clinic
2/27/2023
Discover a one-stop-shop for LNP technologies that provides access to expertise in formulation and analytics for successful outcomes for payload and target applications. Explore end-to-end biopharma services and systems.
-
Realize The Full Potential Of Your RNA Therapeutics: Aldevron's Optimized 5' UTR Backbones
5/6/2026
Reducing immunogenic RNA byproducts while preserving yield is key for mRNA manufacturing. Optimized transcription and capping streamline processing, cut costs, and enable scalable workflows.
-
Nanoplasmid Vector Platform
5/6/2026
Smaller vector backbones boost yield, expression, and transfection while lowering toxicity and regulatory risk, enabling efficient viral, non‑viral, and mRNA workflows from research to clinic.